Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

P2.01-109 Treatment Duration—A More Reasonable Definition to Evaluate the Efficacy of Crizotinib in ALK Positive Advanced NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.09-13 Correlation of ROS1 (SP384) Immunohistochemistry With ROS1 Rearrangement Determined by Fluorescence in Situ Hybridization

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.03-16 Anlotinib Inhibits Angiogenesis of Refractory Advanced Non-Small Cell Lung Cancer via Blocking CCL2 Expression

Journal of Thoracic Oncology

Respiratory Medicine

English

JCSE01.11 Dynamic ctDNA Monitoring Revealed Novel Resistance Mechanisms and Response Predictors of Osimertinib Treatment in East Asian NSCLC Patients

Journal of Thoracic Oncology

Respiratory Medicine

English

OA07.06 Efficacy of Local Consolidative Therapy for Oligometastatic Lung Adenocarcinoma Patients Harboring EGFR Mutations.

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.06-41 Differentiating Sarcomatoid Mesothelioma From Pleomorphic Carcinoma and Chest Wall Sarcoma Using GATA-3/MUC4/BAP1 IHC

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.01-66 Comparison of EGFR Mutation Status in Tissue and Plasma Cell-Free DNA Detected by ARMS in Advanced Lung Adenocarcinoma Patients

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.04-19 Do Advanced Lung Cancer Patients Derive Similar Survival Benefits From Immunotherapy? A Systematic Review and Meta-Analysis

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.06-26 Ribonucleotide Reductase Subunit M1 but Not M2 Is Associated to Better PFS in Patients With Advanced Stage Mesothelioma

Journal of Thoracic Oncology

Respiratory Medicine

English

OA04 Factors Influencing the Non-Administration of Chemotherapies in Patients Who Progressed After First-Line EGFR-TKIs

Journal of Thoracic Oncology

Respiratory Medicine

English